Aug 13, 2024 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Good afternoon. And welcome to the BioCardia second quarter 2024 financial results and business update conference call. (Operator Instructions).
I would now like to turn the call over to Miranda Peto of BioCardia Investor Relations. Please go ahead, Miranda.
Miranda Peto - BioCardia Inc - Investor Relations
Thank you. Good afternoon and thank you for participating in todayâs conference call. Joining me from BioCardiaâs leadership team are Peter Altman Ph.D., President and Chief Executive Officer; and David McClung, the companyâs Chief Financial Officer.
During this call, management will be making forward-looking statements, including statements that address BioCardiaâs expectations for future performance and operational results, references to managementâs intentions, beliefs, projections, outlook, analyses and current expectations. Such factors include, among others, the inherent uncertainties associated with developing new products, technologies and obtaining regulatory approval.
Q2 2024 BioCardia Inc Earnings Call Transcript
Aug 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers